| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ernest Gallo Clinic and Research Center, University of California, San Francisco, California, USA
2Correspondence: Ernest Gallo Clinic and Research Center, 5858 Horton St., Ste. 200, Emeryville, CA 94608, USA. E-mail: jennifer.whistler{at}ucsf.edu
The cannabinoid 1 receptor (CB1R) is one of the most abundant seven transmembrane (7TM) spanning/G-protein-coupled receptors in the central nervous system and plays an important role in pain transmission, feeding, and the rewarding effects of cannabis. Tolerance to cannabinoids has been widely observed after long-term use, with concomitant receptor desensitization and/or down-regulation depending on the brain region studied. Several CB1R agonists promote receptor internalization after activation, but the postendocytic sorting of the receptor has not been studied in detail. Utilizing human embryonic kidney (HEK293) cells stably expressing the CB1R and primary cultured neurons expressing endogenous CB1R, we show that treatment with cannabinoid agonists results in CB1R degradation after endocytosis and that the G-protein-coupled receptor-associated sorting protein GASP1 plays a major role in the postendocytic sorting process. Thus, these results may identify a molecular mechanism underlying tolerance and receptor down-regulation after long-term use of cannabinoids.—Martini, L., Waldhoer, M., Pusch, M., Kharazia, V., Fong, J., Lee, J. H., Freissmuth, C., Whistler, J. L. Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1.
Key Words: degradation • GPCR • postendocytic sorting • tolerance
This article has been cited by other articles:
|
|
 |
|
  C. Borner, M. Smida, V. Hollt, B. Schraven, and J. Kraus Cannabinoid Receptor Type 1- and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling J. Biol. Chem., December 18, 2009; 284(51): 35450 - 35460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ravindranathan, G. Joslyn, M. Robertson, M. A. Schuckit, J. L. Whistler, and R. L. White Functional characterization of human variants of the mu-opioid receptor gene PNAS, June 30, 2009; 106(26): 10811 - 10816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schuligoi, M. Sedej, M. Waldhoer, A. Vukoja, E. M. Sturm, I. T. Lippe, B. A. Peskar, and A. Heinemann Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2 J. Leukoc. Biol., January 1, 2009; 85(1): 136 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Henstridge, N. A. B. Balenga, L. A. Ford, R. A. Ross, M. Waldhoer, and A. J. Irving The GPR55 ligand L-{alpha}-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation FASEB J, January 1, 2009; 23(1): 183 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Niehaus, Y. Liu, K. T. Wallis, M. Egertova, S. G. Bhartur, S. Mukhopadhyay, S. Shi, H. He, D. E. Selley, A. C. Howlett, et al. CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a Mol. Pharmacol., December 1, 2007; 72(6): 1557 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Thompson, M. Pusch, and J. L. Whistler Changes in G Protein-coupled Receptor Sorting Protein Affinity Regulate Postendocytic Targeting of G Protein-coupled Receptors J. Biol. Chem., October 5, 2007; 282(40): 29178 - 29185. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
